Men with high-grade PCa and PSA 2.6-4.0 ng/ml were associated with poorer prognoses than those with PSA 4.0-10.0 ng/ml, but obviously better survival outcomes than those with PSA <2.5 ng/ml. This evidence concerns the gene KLK3 and posterior cortical atrophy.